+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

P

Actively Recruiting

Researchers are evaluating the efficacy and safety of pegozafermin in adults aged 18 to 75 years who have biopsy-confirmed and clinically confirmed compensated cirrhosis caused by metabolic dysfunction-associated steatohepatitis MASH. This phase 3 study aims to compare pegozafermin against a matched placebo to better understand its effects on liver fibrosis and disease progression in this population. Participants will receive either pegozafermin or a placebo through subcutaneous injections. The study is randomized and quadruple-blinded, ensuring neither participants nor researchers know which treatment is given. Treatment effects will be observed over a period of up to 5 years, with primary outcomes measured at 24 months, including fibrosis regression and time to disease progression based on specified clinical events. Throughout the study, participants will undergo regular assessments, including liver function tests like ALT and AST, enhanced liver fibrosis scores, FibroScan elastography, and evaluations for portal hypertension and other liver-related complications. Safety monitoring will track adverse events during the treatment and follow-up period. The trial spans several years, allowing long-term observation of treatment outcomes and participant health.

Age: 18Years - 75YearsAll GendersPhase 3
330 locations
E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating fertiShare, a brief, evidence-based eLearning course designed to support fertility healthcare professionals in sharing bad news with their patients. The study aims to assess the feasibility of implementing fertiShare at fertility clinics and conducting a larger online randomized controlled trial to determine its effectiveness. This research addresses the challenges that fertility staff face when delivering difficult news, which can cause stress and impact patient trust and treatment continuation. The study is a pre-registered, online, multi-center, two-arm, triple-blinded feasibility randomized controlled trial. Participants are randomly assigned to either the fertiShare intervention group, which completes a two-hour self-led eLearning course organized into three modules focusing on sharing bad news and coping strategies, or to a control group receiving a basic communication skills eLearning course. The trial includes six UK-based fertility clinics and involves both fertility healthcare professionals and patients. Participants will be assessed through questionnaires measuring changes in patients perceptions of how staff share bad news, staff confidence, patient trust, satisfaction with care and decision-making, and treatment continuation. Data will be collected at baseline and follow-up timepoints, with some outcomes measured within one week of enrollment and others up to six months later. The study includes process evaluations and safety monitoring, with the total participation period varying by participant.

Age: 18Years +All GendersPhase Not Applicable
5 locations
U

Actively Recruiting

Researchers are conducting a prospective, observational study to assess the health of multiple organs in adults with type 2 diabetes who have no history of cardiovascular disease. The goal is to understand if detailed MRI measurements can help predict future clinical events over a 5-year period. Participants include adults diagnosed with type 2 diabetes, especially those diagnosed within the last three years. Participants will undergo no changes to their standard medical care. The study involves two main visits within one month the first includes body measurements and collection of blood and urine samples for routine diabetes checks, and the second involves a multi-organ, multiparametric MRI scan. Data from these visits, along with access to medical records, will be used to monitor disease progression and predict outcomes over 1, 3, and 5 years. Throughout the 5-year study, researchers will collect MRI metrics, clinical outcomes, and lab samples to evaluate diabetes progression. Participants consent to access their hospital and mortality records for event tracking. The primary outcome is the rate of major cardiovascular events three years after the baseline MRI. Secondary outcomes include kidney, eye, liver, cancer, and mortality events assessed at 1, 3, and 5 years. The study requires only a short period of active participation, with long-term follow-up through record review.

Age: 18Years +All Genders
12 locations